Navigation Links
Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR
Date:11/28/2011

CHICAGO, Nov. 28, 2011 /PRNewswire/ -- Kahn Swick & Foti, LLC announces that the United States District Court Northern District of Illinois Eastern Division approved the following announcement of a proposed class action settlement that would benefit purchasers of publicly-traded securities of Acura Pharmaceuticals, Inc. (NASDAQ: ACUR):

TO: ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED THE PUBLICLY-TRADED SECURITIES OF ACURA PHARMACEUTICALS, INC. ("ACURA PHARMACEUTICALS") (TRADING SYMBOL NASDAQ: ACUR) BETWEEN FEBRUARY 21, 2006, AND APRIL 22, 2010, INCLUSIVE:

YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Northern District of Illinois, Eastern Division, that a hearing will be held on February 16, 2012 at 9:15 a.m., before the Honorable Virginia M. Kendall at the Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 2319, Chicago, IL 60604, for the purpose of determining: (1) whether the proposed Class(1) can be certified for settlement purposes only, pursuant to Federal Rule of Civil Procedure 23; (2) whether the proposed Settlement for the sum of $1,500,000 in cash should be approved by the Court as fair, reasonable and adequate; (3) whether, after the hearing, this Action should be dismissed with prejudice pursuant to the terms and conditions set forth in the Stipulation and Settlement dated as of October 31, 2011; (4) whether the Plan of Allocation is fair, reasonable and adequate and should be approved; and (5) whether the application of Lead Counsel for the payment of attorneys' fees and reimbursement of expenses incurred in this Action should be approved.

If you purchased or otherwise acquired the publicly-traded common stock of Acura Pharmaceuticals, Inc. ("Acura Pharmaceuticals") (trading symbol NASDAQ: ACUR) between February 21, 2006, and April 22, 2010, inclusive, or purchased or otherwise acquired call options on the common stock of Acura Pharmaceuticals between February 21, 2006, and April 22, 2010, inclusive, or sold or otherwise disposed of put options on the common stock of Acura Pharmaceuticals between February 21, 2006, and April 22, 2010, inclusive, your rights may be affected by the Settlement of this Action. If you have not received a detailed Notice of Pendency of Class Action and Proposed Settlement with all Defendants, Motion for Attorneys' Fees and Settlement Fairness Hearing ("Notice") and a copy of the Proof of Claim and Release ("Claim Form"), you should obtain copies by writing to In re Acura Pharmaceuticals, Inc. Securities Litigation, c/o Strategic Claims Services at P.O. Box 230, 600 N. Jackson Street, Suite 3, Media, PA 19063 or by visiting the website of the Claims Administrator at www.strategicclaims.net. The Notice contains details about this Action and Settlement, including what you must do to exclude yourself from the Settlement, object to the terms of the Settlement, or file a Claim Form. If you are a Class Member, in order to share in the distribution of the Net Settlement Fund, you must submit a Claim Form and Release postmarked no later than March 19, 2012, establishing that you are entitled to recovery.

If you desire to be excluded from the Class, you must submit a Request for Exclusion postmarked by February 2, 2012, in the manner and form explained in the detailed Notice referred to above. All Class Members who have not timely and validly requested exclusion from the Class will be bound by any judgment entered in the Action pursuant to the terms and conditions of the Stipulation. Your objection must be postmarked on or before February 2, 2012 and mailed to the Court; Kahn Swick & Foti, LLC, Lead Counsel for Lead Plaintiff and the Class; and Counsel for the Defendants at the following addresses:

COURT:Clerk of the CourtEverett McKinley Dirksen
United States Courthouse219 South Dearborn Street Chicago, IL 60604FOR LEAD PLAINTIFF:Lewis S. Kahn KAHN SWICK & FOTI, LLC206 Covington StreetMadisonville, Louisiana 70447Lead Counsel for Lead Plaintiff and the ClassFOR DEFENDANTS: Sean M. BerkowitzLATHAM & WATKINS LLP233 South Wacker Drive, Suite 5800
Chicago IL 60606Counsel for DefendantsPLEASE DO NOT CONTACT THE COURT OR THE CLERK'S OFFICE REGARDING THIS NOTICE.
If you have any questions about the Settlement, you may contact Lead Counsel for Lead Plaintiffs and the Class at the address listed above.

DATED: NOVEMBER 28, 2011BY ORDER OF THE COURT
UNITED STATES DISTRICT COURT
NORTHERN District of ILLINOIS(1) All capitalized terms not otherwise defined in this document shall have the meaning provided in the stipulation of Settlement, dated October 31, 2011.

Contact:
Strategic Claims Services
(610) 565-9202
Fax: (610) 565-7985
600 N. Jackson Street, Suite 3
Media, PA 19063


'/>"/>
SOURCE Kahn Swick & Foti, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Robbins & Myers Announces Regular Quarterly Cash Dividend
6. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
7. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
8. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
9. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
10. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
11. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 /PRNewswire/ ... healthcare industry. This technique is allowing a previously ... and simplicity. Due to this ability, it is ... will cross US$ 4 Billion by 2022. The ... driven by advancements in computing platforms, rising installation ...
(Date:2/21/2017)... Feb. 21, 2017 Sangamo Therapeutics, Inc. (Nasdaq: ... that the company will release its fourth quarter and ... on Tuesday, February 28, 2017. The press release will ... ET, which will be open to the public via ... will review its financial results and provide a business ...
(Date:2/21/2017)... FALLS, Idaho , Feb. 21, 2017  International ... has completed a private placement with certain investors for ... stock of the Company, Series C Convertible Redeemable Preferred ... accrues dividends at an annual rate of 6% and ... The Company plans to use the proceeds for operating ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... 2017 , ... Each February the nation reflects upon African ... American History Month ). This month-long celebration encourages reflection upon the ... people, but also the opportunity to examine the trends of addiction among African ...
(Date:2/21/2017)... California (PRWEB) , ... February 21, 2017 , ... ... world with over 50,000 participants. The connected care demonstration spanned multiple health ... the National Coordinator, roughly 30% of providers have no Health Information Exchange outside ...
(Date:2/21/2017)... Los Angeles, CA (PRWEB) , ... February 21, 2017 , ... ... the available data on gastric balloons for weight loss. It found that the treatments ... the efforts of obese patients, when compared to unassisted efforts. It also noted very ...
(Date:2/21/2017)... ... February 21, 2017 , ... Along with Valentine’s Day, February marks American ... changes that can lead to a lifetime of heart health. In addition, it ... , The Athletic Trainers’ Society of New Jersey (ATSNJ) is urging sports ...
(Date:2/20/2017)... ... February 20, 2017 , ... MRI screening improves early diagnosis of ... from Germany published online in the journal Radiology . , MRI has ... than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women who have ...
Breaking Medicine News(10 mins):